Aggregates Assembled From Overexpression of Wild-Type α-Synuclein are not Toxic to Human Neuronal Cells

被引:37
作者
Ko, Li-wen [1 ]
Ko, Hwai-hwa C. [1 ]
Lin, Wen-Lang [1 ]
Kulathingal, Jayanranyan G. [1 ]
Yen, Shu-Hui C. [1 ]
机构
[1] Mayo Clin, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA
基金
美国国家卫生研究院;
关键词
alpha-Synuclein; alpha-Synucleinopathy; Cell culture; Inducible transfectant; Lewy body; Parkinson disease;
D O I
10.1097/NEN.0b013e31818c3618
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Filamentous alpha-synuclein (alpha-syn) aggregates form Lewy bodies (LBs), the neuropathologic hallmarks of Parkinson disease and related alpha-synucleinopathies. To model Lewy body-associated neurodegeneration, we generated transfectant 3D5 of human neuronal-type in which expression of human wild-type alpha-syn is regulated by the tetracycline off (TetOff)-inducible mechanism. Retinoic acid-elicited differentiation promoted assembly of alpha-syn aggregates after TetOff induction in 3D5 cells. The aggregates accumulated 14 days after TetOff induction were primarily soluble and showed augmented thioflavin affinity with concomitant phosphorylation and nitration of alpha-syn. Extension of the induction led to the formation of sarkosyl-insoluble aggregates that appeared concurrently with thioflavin-positive inclusions. Immunoelectron microscopy revealed that the inclusions Consist of dense bundles of 8- to 12-nm alpha-syn fibrils that congregate in the perikarya and resemble Lewy bodies. Most importantly, accumulation of soluble and insoluble aggregates after TetOff induction for 14 and 28 days was reversible and did not compromise the viability of the cells or their subsequent survival. Thus, this chemically defined culture paradigm provides a Useful means 10 elucidate how oxidative injuries and other insults that are associated with aging promote alpha-syn to self-assemble or interact with other molecules leading to neuronal degeneration in alpha-synucleinopathies.
引用
收藏
页码:1084 / 1096
页数:13
相关论文
共 66 条
[11]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[12]   The biochemistry of Parkinson's disease [J].
Cookson, MR .
ANNUAL REVIEW OF BIOCHEMISTRY, 2005, 74 :29-52
[13]   Synthetic filaments assembled from C-terminally truncated α-synuclein [J].
Crowther, RA ;
Jakes, R ;
Spillantini, MG ;
Goedert, M .
FEBS LETTERS, 1998, 436 (03) :309-312
[14]   Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions [J].
DeTure, M ;
Ko, LW ;
Yen, S ;
Nacharaju, P ;
Easson, C ;
Lewis, J ;
van Slegtenhorst, M ;
Hutton, M ;
Yen, SH .
BRAIN RESEARCH, 2000, 853 (01) :5-14
[15]   α-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases [J].
Ellis, CE ;
Schwartzberg, PL ;
Grider, TL ;
Fink, DW ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) :3879-3884
[16]   New genetic insights into Parkinson's disease [J].
Feany, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (19) :1937-1940
[17]   α-Synuclein is phosphorylated in synucleinopathy lesions [J].
Fujiwara, H ;
Hasegawa, M ;
Dohmae, N ;
Kawashima, A ;
Masliah, E ;
Goldberg, MS ;
Shen, J ;
Takio, K ;
Iwatsubo, T .
NATURE CELL BIOLOGY, 2002, 4 (02) :160-164
[18]   Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions [J].
Giasson, BI ;
Duda, JE ;
Murray, IVJ ;
Chen, QP ;
Souza, JM ;
Hurtig, HI ;
Ischiropoulos, H ;
Trojanowski, JQ ;
Lee, VMY .
SCIENCE, 2000, 290 (5493) :985-989
[19]   The E46K mutation in α-synuclein increases amyloid fibril formation [J].
Greenbaum, EA ;
Graves, CL ;
Mishizen-Eberz, AJ ;
Lupoli, MA ;
Lynch, DR ;
Englander, SW ;
Axelsen, PH ;
Giasson, BI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) :7800-7807
[20]  
HADJIGEORGIOU GM, 2005, MOVEMENT DISORD, V21, P534